The fact that mutations targeting β-catenin, Axin, and APC occur as early as stage I and their frequency remains constant throughout HCC development suggests that Wnt signaling may nevertheless exert a pro-tumorigenic function at the early stage of HCC development. The gene discussed is AXIN1; the disease is hepatocellular carcinoma.